Urinary symmetric dimethylarginine: A promising biomarker for acute kidney injury in dogs with pyometra
Veterinary Record · 03.10.2026 · 199 (7)
DOI: 10.1002/vetr.70733 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Record, online erschienen am 19.05.2026. Verfasst von Larissa Ayane do Nascimento Braz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Veterinary Surgery, School of Agricultural and Veterinary Sciences, Universidade Estadual Paulista 'Júlio de Mesquita Filh…. Hauptthemen laut MEDLINE: Dog Diseases, Arginine, Acute Kidney Injury, Pyometra. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Symmetric dimethylarginine (SDMA) is a biomarker of renal function derived from arginine methylation, unaffected by muscle mass or diet, and increases after only a 25% reduction in renal function, allowing earlier detection of renal dysfunction compared with serum creatinine. Although serum SDMA is well established in veterinary nephrology, urinary SDMA (uSDMA) remains comparatively underexplored, particularly in dogs with acute kidney injury (AKI). This study evaluated uSDMA concentrations and the uSDMA‐to‐creatinine (uSDMA/Cr) ratio as biomarkers for AKI, using renal histopathology as the reference standard.
Methods
Twenty‐seven non‐azotemic dogs diagnosed with pyometra were evaluated. uSDMA was measured using ELISA, and renal lesions were histopathologically classified as discrete, moderate or severe.
Results
Median uSDMA concentrations were significantly higher in dogs with severe lesions (0.43 µg/mL, interquartile range [IQR] 0.40–0.47) compared with those with moderate lesions (0.31 µg/mL, IQR 0.24–0.38) and discrete lesions (0.26 µg/mL, IQR 0.22–0.30) ( p < 0.001). The uSDMA/Cr ratio was lower in the discrete group (0.0031, IQR 0.0026–0.0036) than in the moderate group (0.0039, IQR 0.0032–0.0048) and the severe group (0.0069, IQR 0.0058–0.0080) ( p = 0.0198).
Limitations
The main limitations include the absence of a healthy control group and lack of serial biomarker measurements, which may restrict the assessment of dynamic changes.
Conclusions
These preliminary findings suggest that uSDMA and uSDMA/Cr ratio may serve as biomarkers for assessing AKI severity in dogs, supporting earlier detection and monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Veterinary Surgery, School of Agricultural and Veterinary Sciences, Universidade Estadual Paulista 'Júlio de Mesquita Filho', Jaboticabal, Brazil.
- Department of Veterinary Medicine, Federal Institute of Southern Minas Gerais, Muzambinho, Brazil.
- Graduate Program in Veterinary Science, College of Veterinary Medicine, Universidade Federal de Uberlândia, Uberlândia, Brazil.
ORCID-Profile: Larissa Ayane do Nascimento Braz, Lara Vilela Soares
Zitieren
APA
Braz, L. A. D. N., Maia, S. R., Soares, L. V., Reis, N. S., Crivellenti, L. Z., & de Nardi, A. B. (2026). Urinary symmetric dimethylarginine: A promising biomarker for acute kidney injury in dogs with pyometra. Veterinary Record, 199(7). https://doi.org/10.1002/vetr.70733
Vancouver
Braz LADN, Maia SR, Soares LV, Reis NS, Crivellenti LZ, de Nardi AB. Urinary symmetric dimethylarginine: A promising biomarker for acute kidney injury in dogs with pyometra. Veterinary Record. 2026;199(7). doi:10.1002/vetr.70733
BibTeX
@article{Braz2026,
author = {Braz, Larissa Ayane do Nascimento and Maia, Suellen Rodrigues and Soares, Lara Vilela and Reis, Natani Silva and Crivellenti, Leandro Zuccolotto and de Nardi, Andrigo Barboza},
title = {Urinary symmetric dimethylarginine: A promising biomarker for acute kidney injury in dogs with pyometra},
journal = {Veterinary Record},
year = {2026},
volume = {199},
number = {7},
doi = {10.1002/vetr.70733}
}
EUVIMED